Research Topic · Peer-Reviewed

Biomarkers for Lung Cancer

A biomarker is a biological or molecular indicator of a particular disease and is used to diagnose and monitor it. In the case of lung cancer, biomarkers are proteins or genetic material that are produced as a result of the disease. They are important tools for identifying the presence and severity of lung cancer as…

Curated from this journal's research 📚 1 peer-reviewed article cited 🗓 Reviewed July 2026

Overview

A biomarker is a biological or molecular indicator of a particular disease and is used to diagnose and monitor it. In the case of lung cancer, biomarkers are proteins or genetic material that are produced as a result of the disease. They are important tools for identifying the presence and severity of lung cancer as well as for tracking its progression. In recent years, biomarkers have been developed for the early detection and diagnosis of lung cancer and for monitoring the efficacy of treatments. By measuring the levels of biomarkers in a patient's blood or tissue, clinicians can accurately diagnose and monitor cases of lung cancer. This leads to better and more effective treatments, thereby improving patient outcomes.

Research published in this journal

1 peer-reviewed article, ranked by relevance. Each links to its DOI.

2018

Molecular Biomarkers: A Brief Review

Tarassishin LeonidCorresponding author
 Department of Biological Sciences.
Proteomics and Genomics Research doi:10.14302/issn.2326-0793.jpgr-18-2418

Editorial oversight

Curated from peer-reviewed research published in Lung Cancer Epidemiology.

Journal editorial board
Krzysztof Roszkowski · Poland Peter Lee · United Kingdom Jonathan Riess · United States

This page summarises published research for orientation; it is not medical or professional advice.